Siemens Launches New Mid-volume Coagulation Analyzer and Celebrates Expanded Portfolio
68th AACC Annual Scientific Meeting & Clinical Lab Expo, Booth 2101
- Enables hemostasis laboratories to standardize testing results across multiple
Sysmex CS and CA hemostasis systems
- Enhances efficiency via a wide optical spectrum, which allows clotting, chromogenic, immunologic and
aggregation1 testing capabilities on a single platform
Today, Siemens Healthineers Laboratory Diagnostics business launched the Sysmex CS-2500 System—a mid-volume, fully-automated
coagulation analyzer with smartly-designed PSI technology—in major markets including the U.S. Together with Lab Alliance of Central
New York, the first U.S. customer to install the high-volume Sysmex CS-5100 System, the company celebrated the availability of its
new Sysmex CS Hemostasis System portfolio in the U.S.
The launch of the new Sysmex CS-2500 System will enable mid-volume laboratories to leverage globally-proven PSI technology,
while providing regional reference laboratories and integrated delivery networks (IDNs) with the ability to standardize testing
results across multiple Sysmex CS and CA hemostasis systems.
“Labs today are challenged to increase their output without sacrificing the accuracy or reliability of their results. The Sysmex
CS Systems are the answer to this demand,” said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers. “The increased
operational efficiency and uninterrupted workflow delivered by the Sysmex CS-5100 and CS-2500 Systems provide our customers with
the confidence, consistency and increased capacity they need to deliver timely and accurate hemostasis test results.”
In most markets, the Sysmex CS-2500 System features simultaneous multiwavelength scanning and proven PSI technologies including
primary-tube sample-volume checks, clog detection, assay-based preanalytical sample-quality checks for hemolysis, icterus and
lipemia (HIL) interference;1 automated mixing studies;1 automated platelet aggregation;1 and clot
waveform analysis (CWA)2 —enabling labs to raise the quality of test results, achieve cost-effective method
consolidation, simplify operations, and increase diagnostic confidence.
The new system enhances efficiency via a wide optical spectrum, which allows clotting, chromogenic, immunologic and
aggregation1 testing capabilities on a single platform. With an onboard capacity of up to 3,000 tests3 and up
to 40 reagents, the Sysmex CS-2500 System delivers extended walkaway time to streamline workflow.
Anne Chamberlain, Hematology Manager at Laboratory Alliance of Central New York, remarked, “The Sysmex CS Systems and the
services offered by Siemens Healthineers are the perfect fit for our laboratory and laboratory networks similar to ours. The
intuitive system software, readily accessible patient analysis data and result traceability simplifies our operations. This enables
our lab to deliver quality test results, which positively impacts patient care for our clients.”
To help labs ensure consistency and improve productivity, the systems use the same reagents, controls and calibrators as other
coagulation analyzers offered by Siemens Healthineers.
For more information about the Sysmex CS-2500 System, please visit: http://www.healthcare.siemens.com/hemostasis/systems/sysmex-cs-2500-system
1. |
|
The features (mentioned herein) are not commercially available in all countries. Due
to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for
further details. |
2. |
|
For Research Use Only. Not for use in diagnostic procedures. |
3. |
|
Based on internal validation data from Sysmex Corporation. |
Follow us on Twitter at www.twitter.com/siemenshealth.
The products/features mentioned here are not commercially available in all countries. Due to regulatory reasons their future
availability cannot be guaranteed. Further details are available from the local Siemens organizations.
Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation,
quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries,
focusing on the areas of electrification, automation and digitalization. One of the world’s largest producers of energy-efficient,
resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of gas and steam
turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well
as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment –
such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT.
In fiscal 2015, which ended on September 30, 2015, Siemens generated revenue of €75.6 billion and net income of
€7.4 billion. At the end of September 2015, the company had around 348,000 employees worldwide. Further information is
available on the Internet at www.siemens.com.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20160803005023r1&sid=mstr1&distro=nx&lang=en)
Siemens Healthineers
Kimberly Nissen, +1 610-448-6355
kimberly.nissen@siemens.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160803005023/en/